AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anterix Inc. Director's Dealing 2025

Jan 24, 2025

33018_dirs_2025-01-24_d0499307-6ff6-43cd-bce5-702a7ac643e3.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anterix Inc. (ATEX)
CIK: 0001304492
Period of Report: 2025-01-22

Reporting Person: Kuhn Thomas R. (Director, Chairman)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-01-22	Stock Option (Right to Buy)	$29.84	A	56803	Acquired	2035-01-22	Common Stock (56803)	Direct

Footnotes

F1: The option shares shall vest in full and become exercisable on January 22, 2028, subject to the Reporting Person's continued service with the Issuer through this date.